neoplasm
• decreased tumor latency by 10 weeks
• 2-fold increased mammary tumor risk
• increased mammary tumor incidence
• decreased mammary tumor-free survival
|
integument
• decreased tumor latency by 10 weeks
• 2-fold increased mammary tumor risk
• increased mammary tumor incidence
• decreased mammary tumor-free survival
|
endocrine/exocrine glands
• decreased tumor latency by 10 weeks
• 2-fold increased mammary tumor risk
• increased mammary tumor incidence
• decreased mammary tumor-free survival
|